Monkey PoxNCT05543577
Assessing the Preparedness and Knowledge of Pharmacists in the Current Monkeypox Outbreak
An observational study of Monkey Pox, run by Beni-Suef University at 1 site in Egypt.
Trial summary
General objective: to measure the preparedness of pharmacists and medical interns about monkeypox Specific objectives: to evaluate the level of knowledge among pharmacists and medical interns about monkeypox treatment and nature of disease Read more about this study
- Who is it for?
- Any ageHealthy volunteers can take part
- Conditions the study is for
- Monkey Pox
- What is being tested?
- Questionnaire
- How many people
- 500 participants
- Where
- 1 siteEgypt
- Study dates
- 14 Sep 2022to 1 Dec 2022
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Study population: community, hospital and clinical pharmacists, Medical interns of both sexes and any age
Who may be able to join
- community, hospital and clinical pharmacists, Medical interns of both sexes
Who cannot join
- any other healthcare professional
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Comparative Study of the Preparedness and Knowledge of Pharmacists Versus Intern Physician in the Current Monkeypox Outbreak
General objective: to measure the preparedness of pharmacists and medical interns about monkeypox
Specific objectives: to evaluate the level of knowledge among pharmacists and medical interns about monkeypox treatment and nature of disease
Read the detailed description
Globally, the ongoing outbreak was declared as a public health emergency. After the first laboratory-confirmed case of monkeypox was reported in Singapore on May 2019, countries all over the world started to strengthen disease surveillance systems. One challenge in preventing monkeypox is a lack of knowledge, particularly among healthcare workers.
Study significance: to examine in detail the preparedness and the perception of pharmacists and medical interns about monkeypox and to evaluate the level of knowledge about monkeypox management and nature of disease.
- Conditions
- Monkey Pox
- Being tested
- Questionnaire
- Medical subject headings
- Mpox, Monkeypox
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
QuestionnaireOther
Questionnaire
| Study group | Role | What they receive |
|---|---|---|
| Pharmacists | community, hospital and clinical pharmacists Receives: Other: Questionnaire | |
| Medical interns | Medical interns of both sexes Receives: Other: Questionnaire |
What is being measured
The primary outcome is the main question the study is designed to answer.
the level of knowledge among pharmacists and medical interns about monkeypox treatment and nature of disease using an online Questionnaire
the level of knowledge among pharmacists and medical interns about monkeypox treatment and nature of disease using a validated questionnaire
Measured: 2 months
Direct interviews with the pharmacists and medical interns to assess their knowledge and attitudes about diagnosing and dealing with the Monkeypox infected cases
Direct interviews with the pharmacists and medical interns to assess their knowledge and attitudes about diagnosing and dealing with the Monkeypox infected cases
Measured: 2 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Sep 2022
- Study start14 Sep 2022
- Primary completion1 Nov 2022
- Study completion1 Dec 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Monkey PoxStudies of the same condition, open and under way.
- More trials run by Beni-Suef UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 500 participants (actual)
Sponsor and investigators
- Lead sponsor
- Beni-Suef University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Asmaa Abdelfattah Elsayed, Beni-Suef University
- Investigators
- Engy Wahsh, Ph.D., Study director, 6october University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05543577
- Sponsor's protocol ID
- BeniSuefU2022
- Status last verified
- Nov 2023
- First submitted
- 14 Sep 2022
- Last updated
- 5 Dec 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: only the PI will keep the data and have access to the questionnaire
Study at a glance
From the registry record, last updated by the sponsor on 5 Dec 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparative Study of the Preparedness and Knowledge of Pharmacists Versus Intern Physician in the Current Monkeypox Outbreak
- ClinicalTrials.gov ID
- NCT05543577
- Acronym / sponsor ID
- BeniSuefU2022
- Conditions
- Monkey Pox
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 500 participants (actual)
- Lead sponsor
- Beni-Suef UniversityUniversity, hospital or other
- Study start
- 14 Sep 2022 (actual)
- Primary completion
- 1 Nov 2022 (actual)
- Study completion
- 1 Dec 2022 (actual)
- First posted
- 16 Sep 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
General objective: to measure the preparedness of pharmacists and medical interns about monkeypox
Specific objectives: to evaluate the level of knowledge among pharmacists and medical interns about monkeypox treatment and nature of disease
Detailed description
Globally, the ongoing outbreak was declared as a public health emergency. After the first laboratory-confirmed case of monkeypox was reported in Singapore on May 2019, countries all over the world started to strengthen disease surveillance systems. One challenge in preventing monkeypox is a lack of knowledge, particularly among healthcare workers.
Study significance: to examine in detail the preparedness and the perception of pharmacists and medical interns about monkeypox and to evaluate the level of knowledge about monkeypox management and nature of disease.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Pharmacists | – | Other: Questionnairecommunity, hospital and clinical pharmacists |
| Medical interns | – | Other: QuestionnaireMedical interns of both sexes |
Who may qualify
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
- Study population
- community, hospital and clinical pharmacists, Medical interns of both sexes and any age
Key inclusion criteria (1 listed)
- community, hospital and clinical pharmacists, Medical interns of both sexes
Key exclusion criteria (1 listed)
- any other healthcare professional
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| QuestionnaireQuestionnaire | Other | Medical interns, Pharmacists |
Primary outcome
the level of knowledge among pharmacists and medical interns about monkeypox treatment and nature of disease using an online Questionnaire
Time frame: 2 months
the level of knowledge among pharmacists and medical interns about monkeypox treatment and nature of disease using a validated questionnaire
Direct interviews with the pharmacists and medical interns to assess their knowledge and attitudes about diagnosing and dealing with the Monkeypox infected cases
Time frame: 2 months
Direct interviews with the pharmacists and medical interns to assess their knowledge and attitudes about diagnosing and dealing with the Monkeypox infected cases
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Dec 2023.
- Related InfoLink provided by the sponsor.
- Individual participant dataSharing planned: No. only the PI will keep the data and have access to the questionnaire
Related trials for Monkey Pox
Active, not recruitingPhase 1
A Clinical Trial Evaluating the Monkeypox Recombinant Protein Vaccine
Health Volunteer
RecruitingObservational study
Evaluation of Effectiveness and Safety of LC16m8 Mpox Vaccine in the Democratic Republic of Congo (DRC)
Mpox (Monkeypox), Mpox
Enrolling by invitationObservational study
New York City Observational Study of Mpox Immunity
Monkeypox, Mpox
Enrolling by invitation
Smart Analysis and Decision-Making for Emerging Infectious Diseases
Emerging Infectious Diseases, COVID-19
Active, not recruitingPhase 4
Smallpox Vaccine for Mpox Post-Exposure Prophylaxis: A Cluster RCT
Monkeypox
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Engy Wahsh, Ph.D. study director
6october University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Monkey Pox, run by Beni-Suef University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 5 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
the level of knowledge among pharmacists and medical interns about monkeypox treatment and nature of disease using an online Questionnaire (time frame: 2 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Dec 2023.